FDA clears 3 C-arms from Siemens Healthcare

Michael Walter | | Radiology Business | Medical Imaging

Siemens Healthcare announced this week that three models from the company’s line of Cios C-arms—Cios Fusion, Cios Connect, and Cios Select—have been cleared by the FDA.

“With the addition of these three new mobile C-arms to the Cios family, Siemens Healthcare is proud to build on our tradition of C-arm leadership,” Martin B. Silverman, Siemens Healthcare vice president of x-ray products, said in a prepared statement. “Our Cios family offers customers a complete product portfolio that meets their needs, regardless of facility type or budget. These expanded mobile C-arm offerings represent another example of how Siemens innovates to solve the daily real-world challenges facing hospitals and surgical centers.”

The company’s Cios Fusion falls in “the medium price segment,” and includes two detector sizes and a touchscreen remote. Cios Connect weighs 547 pounds, giving surgeons the ability to perform numerous applications. Cios Select, meanwhile, is an entry-level C-arm, equipped with a push button interface for simplified use.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

U.S. moves closer to establishing domestic supply of Mo-99 for nuclear imaging
RSNA 2024 Program Chair Kate Hanneman highlights key trends in radiology
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage
Radiologists are more accurate, confident when they know the full story
GE HealthCare moves PET/CT scanner production to United States
Use of AI opportunistic screening in CT for cardiovascular disease

Around the web

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.